Caroline Ballet has 10 years of experience in leading projects in Healthcare companies. Since 2015, she coordinates the development of TOLLYS TL-532 with a focus on Safety preclinical studies, chemistry manufacturing and controls, product formulation and bioanalytics. She is also involved in collaborative project management and public fund raising.
Caroline Ballet has a PhD in immunolgy from the University of Nantes, France and a Magister of Biotechnology and Entreprenership from the ESI Business School (Grenoble, France).
She began her carrier at Parteurop (Lyon, France), a consultancy company, where she lead projects in the field of vaccines, moncolonal antibodies, red blood cells therapies and vectorization in various indications including cancer, transplantation, autoimmune and infectious diseases.
Cutting-Edge Cancer Immunotherapy
60F avenue Rockefeller
69008 Lyon, FRANCE